By inhibiting ALDH1A1 and ALDH3A1, it may be possible to overcome resistance to chemotherapy and enhance the efficacy of existing cancer treatments, providing new avenues for combating resistant cancer types. This evidence concerns the gene ALDH3A1 and cancer.